Kiniksa Pharmaceuticals International, plc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
Kiniksa Pharmaceuticals International, plc (KNSA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2026-03-31 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-12-31 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-09-30 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-06-30 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2024 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2022 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2021 was $0.00.
- Kiniksa Pharmaceuticals International, plc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2020 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 24 month |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $0.00 derived: sum of 3 quarters · filed 2026-04-28 | $0.00 derived: sum of 4 quarters · filed 2026-04-28 | |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $0.00 derived: sum of 3 quarters · filed 2026-04-28 | $0.00 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $0.00 10-Q · filed 2025-07-29 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | $0.00 10-K · filed 2025-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2024-10-29 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | $0.00 derived: sum of 3 quarters · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2024-10-29 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 derived: sum of 3 quarters · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2024-10-29 | |
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 derived: sum of 3 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |